Role of bone marrow-derived cells in the genetic control of restenosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 29, Issue 10, 2009, Pages 1551-1557

  Langwieser, Nicolas ^a   Schwarz, Johannes B K ^a   Reichenbächer, Christoph ^b   Stemmer, Bastian ^b   Massberg, Steffen ^b   Langwieser, Nicole N ^a   Zohlnhöfer, Dietlind ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bone marrow cells; Hematopoietic stem and progenitor cells; Inflammation; Vascular remodeling

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, MOUSE; LY ANTIGEN; LY6A PROTEIN, MOUSE; MEMBRANE PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; C57BL 6 MOUSE; CELL FUNCTION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC REGULATION; HEMATOPOIETIC STEM CELL; HYPERPLASIA; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; INTIMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; TISSUE REPAIR; ANIMAL; C57BL MOUSE; CELL MOTION; ENDOTHELIUM CELL; FEMORAL ARTERY; GENE EXPRESSION PROFILING; GENETICS; PATHOLOGY; PHYSIOLOGY; SPECIES DIFFERENCE; VASCULAR DISEASE;

ANIMALS; ANTIGENS, LY; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL MOVEMENT; ENDOTHELIAL CELLS; FEMORAL ARTERY; GENE EXPRESSION PROFILING; HYPERPLASIA; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; RECEPTORS, CXCR4; SPECIES SPECIFICITY; TUNICA INTIMA; VASCULAR DISEASES;

EID: 70349567933     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.188326     Document Type: Article

References (29)

1. Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9: 653-660.
2. Mintz GS, Kent KM, Pichard AD, Popma JJ, Satler LF, Leon MB. Intravascular ultrasound insights into mechanisms of stenosis formation and restenosis. Cardiol Clin. 1997;15:17-29.
3. Mintz GS, Popma JJ, Hong MK, Pichard AD, Kent KM, Satler LF, Leon MB. Intravascular ultrasound to discern device-specific effects and mechanisms of restenosis. Am J Cardiol. 1996;78:18-22.
4. Ueda M, Becker AE, Tsukada T, Numano F, Fujimoto T. Fibrocellular tissue response after percutaneous transluminal coronary angioplasty. An immunocytochemical analysis of the cellular composition. Circulation. 1991;83:1327-1332.
5. Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation. 2002;105:2974-2980. (Pubitemid 34693829)
6. Simon DI, Dhen Z, Seifert P, Edelman ER, Ballantyne CM, Rogers C. Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty. J Clin Invest. 2000; 105:293-300.
7. Tanaka K, Sata M, Hirata Y, Nagai R. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res. 2003;93:783-790.
8. Zernecke A, Schober A, Bot I, von Hundelshausen P, Liehn EA, Mopps B, Mericskay M, Gierschik P, Biessen EA, Weber C. SDF-1al-pha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res. 2005;96: 784-791.
9. Zohlnhofer D, Klein CA, Richter T, Brandl R, Murr A, Nuhrenberg T, Schomig A, Baeuerle PA, Neumann FJ. Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: Detection of FK506-binding protein 12 upregulation. Circulation. 2001;103:1396-1402.
10. Schomig A, Kastrati A, Elezi S, Schuhlen H, Dirschinger J, Dannegger F, Wilhelm M, Ulm K. Bimodal distribution of angiographic measures of restenosis six months after coronary stent placement. Circulation. 1997; 96:3880-3887.
11. Harmon KJ, Couper LL, Lindner V. Strain-dependent vascular remodeling phenotypes in inbred mice. Am J Pathol. 2000;156: 1741-1748.
12. Nuhrenberg TG, Langwieser N, Schwarz JB, Hou Y, Frank P, Sorge F, Matschurat S, Seidl S, Kastrati A, Schomig A, Clauss MA, Zohlnhofer D. EMAP-II downregulation contributes to the beneficial effects of rapamycin after vascular injury. Cardiovasc Res. 2008;77:580-589.
13. Amadou C, Kumanovics A, Jones EP, Lambracht-Washington D, Yoshino M, Lindahl KF. The mouse major histocompatibility complex: some assembly required. Immunol Rev. 1999;167:211-221.
14. Zohlnhofer D, Richter T, Neumann F, Nuhrenberg T, Wessely R, Brandl R, Murr A, Klein CA, Baeuerle PA. Transcriptome analysis reveals a role of interferon-gamma in human neointima formation. Mol Cell. 2001;7: 1059-1069.
15. Nührenberg TG, Voisard R, Fahlisch F, Rudelius M, Braun J, Gschwend J, Kountides M, Herter T, Baur R, Hombach V, Baeuerle PA, Zohlnhöfer D. Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty. Faseb J. 2005;19:246-248.
16. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002;8:403-409.
17. Sibilia M, Wagner EF. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science. 1995;269:234-238.
18. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science. 1995;269:230-234.
19. Melgarejo E, Medina MA, Sanchez-Jimenez F, Urdiales JL. Monocyte chemoattractant protein-1: A key mediator in inflammatory processes. Int J Biochem Cell Biol. 2009;41:998-1001.
20. Hamilton JA. Colony-stimulating factors in inflammation and autoim-munity. Nat Rev Immunol. 2008;8:533-544.
21. Moser B, Loetscher M, Piali L, Loetscher P. Lymphocyte responses to chemokines. Int Rev Immunol. 1998;16:323-344.
22. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Rafii S. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002;109:625-637.
23. Pelus LM, Fukuda S. Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties. Exp Hematol. 2006;34:1010-1020.
24. Jo DY, Rafii S, Hamada T, Moore MA. Chemotaxis of primitive hema-topoietic cells in response to stromal cell-derived factor-1. J Clin Invest. 2000;105:101-111.
25. Edling CE, Hallberg B. c-Kit-a hematopoietic cell essential receptor tyrosine kinase. Int J Biochem Cell Biol. 2007;39:1995-1998.
26. Werner N, Priller J, Laufs U, Endres M, Bohm M, Dirnagl U, Nickenig G. Bone marrow-derived progenitor cells modulate vascular reendothe-lialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol. 2002;22:1567-1572.
27. Jiang S, Walker L, Afentoulis M, Anderson DA, Jauron-Mills L, Corless CL, Fleming WH. Transplanted human bone marrow contributes to vascular endothelium. Proc Natl Acad Sci U S A. 2004;101: 16891-16896.
28. Sahara M, Sata M, Matsuzaki Y, Tanaka K, Morita T, Hirata Y, Okano H, Nagai R. Comparison of various bone marrow fractions in the ability to participate in vascular remodeling after mechanical injury. Stem Cells. 2005;23:874-878.
29. Shiba Y, Takahashi M, Yoshioka T, Yajima N, Morimoto H, Izawa A, Ise H, Hatake K, Motoyoshi K, Ikeda U. M-CSF accelerates neointimal formation in the early phase after vascular injury in mice: the critical role of the SDF-1-CXCR4 system. Arterioscler Thromb Vasc Biol. 2007;27: 283-289.